Serina Therapeutics, Inc. (AMEX:SER) Financings

Serina Therapeutics, Inc.

Financings

RaiseDate
At-the-market programme of common stock
Tranche closed: US$6 a share · JonesTrading Institutional Services LLC
Dealers: JonesTrading Institutional Services LLC (lead)
Nov 13, 2025
Financing agreement tranche
Tranche closed: US$5M raised · US$5.18 a share · Warrants at US$5.44
Buyers: Greg Bailey, MD (leads the up to $20 million financing)
Insiders: Financing led by Serina Board Director Greg Bailey, MD
Use of proceeds: Advance the planned registrational trial of SER-252 for advanced Parkinson's disease
Oct 6, 2025

Read by 6ix AI from the company's releases